Computational nanochemistry report on the oxicams--conceptual DFT indices and chemical reactivity.
Martínez-Araya JI, Salgado-Morán G, Glossman-Mitnik D.
J Phys Chem B · research support, non-u.s. gov't; journal article · DOI 10.1021/jp400241q PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för droxicam. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
24 träffarElectrochemical behaviour of droxicam: kinetic study in aqueous-organic media.
Acuña JA, de la Fuente C, Vázquez MD, Tascón ML, Gómez MI, Mata F, Sánchez-Batanero P.
J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/s0731-7085(02)00041-9[Chronic autoimmune hepatitis following cholestatic hepatitis caused by droxicam].
Pérez-Aguilar F, Berenguer M, Ramírez-Palanca JJ, Payà A, Vera-Sempere FJ, Sánchez-Cuenca JM, Berenguer J.
Med Clin (Barc) · journal article; case reports[Droxicam-induced toxic hepatitis].
Berenguer M, Pérez-Aguilar F, Gisbert C, Ferreres LA, Vera-Sempere FJ, Berenguer J.
Rev Esp Enferm Dig · journal article; case reportsA comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
Maya MT, Pais JP, Ruas Da Silva J, Morais JA.
Eur J Drug Metab Pharmacokinet · comparative study; clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1007/bf03190244[Hepatotoxicity induced by Droxicam: presentation of 4 cases].
Morillas Ariño J, Sánchez de la Fuente MF, García-Cano Lizcano J, Jiménez Sánchez F, Rosa Herranz C, Razquin Murillo J, Pérez Sola A, González Martín JA.
Rev Esp Enferm Dig · journal article; case reports[Efficacy of and tolerance to a new NSAID in the treatment of arthrosis: droxicam. Randomized study versus tenoxicam].
Chevallard M, Venegoni C, Colombo B.
Minerva Med · comparative study; clinical trial; randomized controlled trial; journal articleThe effect of antacid and ranitidine on droxicam pharmacokinetics.
Bartlett A, Costa A, Martínez L, Roser R, Sagarra R, Sánchez J.
J Clin Pharmacol · comparative study; journal article · DOI 10.1177/009127009203201210[Toxic hepatitis caused by droxicam].
Cancelo Suárez P, Prieto de Paula JM, de la Cueva Gallo JA, Velasco Osés A.
Med Clin (Barc) · letter; comment; case reports[Toxic hepatitis caused by droxicam].
Caballería Rovira E, Aragó López JV, Massó Ubeda RM, Sanchís Closa A.
Med Clin (Barc) · letter; comment; case reports[Toxic hepatitis caused by droxicam].
Rosselló T, Fiol F.
Med Clin (Barc) · letter; comment; case reports[Toxic hepatitis caused by droxicam].
López-Tierra G, Merino MJ, Gómez-Camacho E, Ollero M.
Med Clin (Barc) · letter; case reportsPharmacokinetic profile of droxicam.
Martínez L, Sánchez J.
Eur J Rheumatol Inflamm · review; journal articleTherapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
Schüetz E, Sánchez J, García-Barbal J, Sarti JF, Reuter C, Harrison FJ.
Eur J Rheumatol Inflamm · comparative study; clinical trial; randomized controlled trial; journal articleDouble-blind, randomized and parallel comparison between droxicam and diclofenac sodium in patients with coxarthrosis and gonarthrosis.
Corts Giner JR, García Borrás JJ.
Eur J Rheumatol Inflamm · comparative study; clinical trial; randomized controlled trial; journal articleComparative double-blind study of droxicam (new NSAID) versus indomethacin in rheumatoid arthritis.
Rodríguez-de-la-Serna A, Geli-Ferrer C, Diaz-López C, Sánchez-García J.
Eur J Rheumatol Inflamm · comparative study; clinical trial; randomized controlled trial; journal articleA pharmacokinetic study to evaluate the profile of droxicam in elderly healthy volunteers after a single oral dose of 20mg.
Hosie J, Kelly J, Sánchez J, Bartlett A, Harrison FJ.
Eur J Rheumatol Inflamm · clinical trial; journal articleAdverse events with droxicam in the early clinical trials.
Sánchez J, Bartlett A, Costa A, Estruch J, Estiarte R, Soucheiron C.
Eur J Rheumatol Inflamm · journal articleThe influence of gastric emptying on droxicam pharmacokinetics.
Sánchez J, Martínez L, García-Barbal J, Roser R, Bartlett A, Sagarra R.
J Clin Pharmacol · journal article · DOI 10.1002/j.1552-4604.1989.tb03409.xComparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
Martínez L, Sánchez J, Roser R, García-Barbal J, Bartlett A, Estruch J, Sagarra R, Puig S, Costa A.
Methods Find Exp Clin Pharmacol · comparative study; clinical trial; randomized controlled trial; journal articlePharmacological profile of droxicam.
Esteve J, Farré AJ, Roser R.
Gen Pharmacol · review; journal article · DOI 10.1016/0306-3623(88)90004-3Effects of droxicam on in vivo prostaglandin synthesis and ex vivo platelet aggregation.
Esteve J, Martínez L, Roser R, Sagarra R.
Methods Find Exp Clin Pharmacol · journal articlePharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.
Farré AJ, Colombo M, Fort M, Gutiérrez B, Rodríguez L, Roser R.
Methods Find Exp Clin Pharmacol · journal articlePharmacokinetics of droxicam in rat and dog.
Esteve A, Martínez L, Roser R, Sagarra R.
Methods Find Exp Clin Pharmacol · comparative study; journal article